Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Proceedings of the National Academy of Sciences of the United States of America · 2025
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Julia Erber *Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0003-4019-4180
Carmen Stecher *Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0002-1308-4544
Valerie PlajerDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0003-3987-9078
Nina BraunCenter for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.
William MallardDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
Loyal A GoffDepartment of Neuroscience, Johns Hopkins University, Baltimore, MD 21205.ORCID 0000-0003-2875-451X
Iros BarozziCenter for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0003-0690-3473
Thomas MohrCenter for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0002-1933-847X
John L RinnBioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.ORCID 0000-0002-7231-7539
Richard A FlavellDepartment of Immunobiology, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0003-4461-0778
Dietmar Herndler-BrandstetterCenter for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.ORCID 0000-0003-0987-0208
Funding
Austrian Science Fund (FWF) 10.55776/P33340Austrian Science Fund (FWF) 10.55776/P36995
6 · The paper itself
Abstract
CD8
Indexed as
CD8-Positive T-LymphocytesCell DifferentiationImmunologic MemoryRNA, Long NoncodingAnimalsHumansInhibitor of Differentiation Protein 2Lectins, C-TypeMemory T CellsMiceMice, Inbred C57BLMice, KnockoutReceptors, ImmunologicT-bet Transcription FactorT-Box Domain ProteinsIdb2 protein, mouseInhibitor of Differentiation Protein 2Klrg1 protein, mouseLectins, C-TypeReceptors, ImmunologicRNA, Long NoncodingT-bet Transcription FactorT-Box Domain ProteinsCD8 T cell differentiationcytotoxic T cellinfectionknockout mouse modellong noncoding RNA
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.